Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02000284 · ClinicalTrials.gov registry record
Mitochondrial Dysfunction in Autism Spectrum Disorder
A clinical trial of Autism Spectrum Disorder and Autism, sponsored by University of Arkansas.
- Active
- Registry status
- 297
- Enrollment target
- 1
- Study location
NCT02000284 is a study of Autism Spectrum Disorder and Autism that is active but no longer recruiting, run by University of Arkansas. The registered enrollment target is 297 participants, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (122% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02000284, a study of Autism Spectrum Disorder and Autism, is active but no longer recruiting, sponsored by University of Arkansas.
- ACTIVE NOT RECRUITING
- Registry status
- 297 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers at Arkansas Children's Hospital Research Institute are conducting a study about mitochondrial function in children. The study involves up to 5 visits to Arkansas Children's Hospital with fasting blood draws, behavioral assessments, and/or questionnaires. This study is not currently recruiting, but continues to follow those who were enrolled. There is no cost for visits or study-related exams. For further information, please contact the program manager, Leanna Delhey, at ldelhey@uams.edu or 501-364-4519
Conditions Studied
Study Locations (1)
Tennessee
- The University of Tennessee Health Science Center - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 297 participants |
| Start Date | 2012-10-16 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02000284
The ClinicalTrials.gov registry entry for NCT02000284 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 297 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (122% higher). The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT02000284 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT02000284 about?
NCT02000284 is a clinical study titled "Mitochondrial Dysfunction in Autism Spectrum Disorder". Researchers at Arkansas Children's Hospital Research Institute are conducting a study about mitochondrial function in children. The study involves up to 5 visits to Arkansas Children's Hospital with fasting blood draws, behavioral assessments, and/or questionnaires. This study is not currently recr...
What is the current status of trial NCT02000284?
This trial is currently active not recruiting. The enrollment target is 297 participants. The study started on 2012-10-16. Estimated completion is 2027-12-31.
What conditions does trial NCT02000284 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Autism, Developmental Delay, Mitochondrial Disease.
Who is sponsoring clinical trial NCT02000284?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02000284 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design
RECRUITING · Early Phase 1
-
Cannabidiol (CBD) in Adults With ASD
RECRUITING · Phase 1
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
RECRUITING · Phase 2
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.